What is the address of ALGEMENE AANNEMING ANTWERPEN THERMAC?

The registered office of ALGEMENE AANNEMING ANTWERPEN THERMAC is located at Hemelrijk 36, 2910 Essen.

Is ALGEMENE AANNEMING ANTWERPEN THERMAC still active?

Yes. According to the CBE (30 October 2026) ALGEMENE AANNEMING ANTWERPEN THERMAC is active, legal situation “Normale toestand”, started on 12 August 1985.

Is ALGEMENE AANNEMING ANTWERPEN THERMAC registered on Peppol?

Yes, ALGEMENE AANNEMING ANTWERPEN THERMAC is registered on the Peppol network with ID 0208:0427579463.

What is the enterprise number of ALGEMENE AANNEMING ANTWERPEN THERMAC?

The enterprise number of ALGEMENE AANNEMING ANTWERPEN THERMAC is BE0427579463.

When was ALGEMENE AANNEMING ANTWERPEN THERMAC founded?

ALGEMENE AANNEMING ANTWERPEN THERMAC was founded on 12 August 1985.

Who are the directors of ALGEMENE AANNEMING ANTWERPEN THERMAC?

According to the 2025 annual accounts, the directors of ALGEMENE AANNEMING ANTWERPEN THERMAC are: Holding LVT BV.

Is ALGEMENE AANNEMING ANTWERPEN THERMAC a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 12 August 1985; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did ALGEMENE AANNEMING ANTWERPEN THERMAC make in 2025?

ALGEMENE AANNEMING ANTWERPEN THERMAC posted a profit after taxes of € 269,828 in financial year 2025.

What is the revenue of ALGEMENE AANNEMING ANTWERPEN THERMAC?

As a small company, ALGEMENE AANNEMING ANTWERPEN THERMAC is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 318,413.

How many employees does ALGEMENE AANNEMING ANTWERPEN THERMAC have?

According to the 2025 annual accounts, ALGEMENE AANNEMING ANTWERPEN THERMAC has 0 full-time equivalents (FTE).

ALGEMENE AANNEMING ANTWERPEN THERMAC (Private Limited)

Dossier ALGEMENE AANNEMING ANTWERPEN THERMAC, printed on 30 October 2026 from databakkes.be/en/0427579463/algemene-aanneming-antwerpen-thermac. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

ALGEMENE AANNEMING ANTWERPEN THERMAC from Essen, company number BE0427579463, closed financial year 2025 with a result of € 269,828 after tax. For that financial year ALGEMENE AANNEMING ANTWERPEN THERMAC recorded a gross margin of € 318,413 and equity of € 76,838. Compared with financial year 2024, the result moved from € 3,506 to € 269,828. Profitable, and profit is growing. The buffer is growing. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on July 3, 2026.

What it is worth Growing

€ 76,838

▲ € 72,554 vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 269,828

▲ € 266,322 vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 114,488

▲ € 95,326 vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € 58,088.

People and assets in 2025

Full-time equivalents

Average over the fiscal year, from the social balance sheet.

Debts at end 2025

Bank debt ≈ 7 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 94,699

▼ 39% vs 2024

€ 13,767 is repaid this year. At this pace the long-term loan is gone in ≈ 7 years.

Owed to suppliers

€ 500

▼ 93% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 15,805

▲ € 13,654 vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 114,469 Gross margin 2022: € 114,469 First fiscal year in the series	€ 12,798 Gross margin 2023: € 12,798 ▼ 89% vs 2022 (€ 114,469) Unfavourable step	€ 34,595 Gross margin 2024: € 34,595 ▲ 170% vs 2023 (€ 12,798) Favourable step	€ 318,413 Gross margin 2025: € 318,413 ▲ € 283,818 vs 2024 (€ 34,595) Favourable step	▲ € 283,818
Profit after taxes	€ 38,964 Profit after taxes 2022: € 38,964 First fiscal year in the series	€ -7,364 Profit after taxes 2023: € -7,364 ▼ € 46,328 vs 2022 (€ 38,964) Unfavourable step	€ 3,506 Profit after taxes 2024: € 3,506 ▲ € 10,869 vs 2023 (€ -7,364) Favourable step	€ 269,828 Profit after taxes 2025: € 269,828 ▲ € 266,322 vs 2024 (€ 3,506) Favourable step	▲ € 266,322
Equity	€ -189,132 Equity 2022: € -189,132 First fiscal year in the series	€ 779 Equity 2023: € 779 ▲ € 189,910 vs 2022 (€ -189,132) Favourable step	€ 4,284 Equity 2024: € 4,284 ▲ € 3,506 vs 2023 (€ 779) Favourable step	€ 76,838 Equity 2025: € 76,838 ▲ € 72,554 vs 2024 (€ 4,284) Favourable step	▲ € 72,554
Total debts	€ 479,287 Total debts 2022: € 479,287 First fiscal year in the series	€ 462,462 Total debts 2023: € 462,462 ▼ 4% vs 2022 (€ 479,287) Favourable step	€ 438,708 Total debts 2024: € 438,708 ▼ 5% vs 2023 (€ 462,462) Favourable step	€ 226,377 Total debts 2025: € 226,377 ▼ 48% vs 2024 (€ 438,708) Favourable step	▼ 48%
Cash	€ 12,064 Cash 2022: € 12,064 First fiscal year in the series	€ 4,108 Cash 2023: € 4,108 ▼ 66% vs 2022 (€ 12,064) Unfavourable step	€ 19,162 Cash 2024: € 19,162 ▲ € 15,054 vs 2023 (€ 4,108) Favourable step	€ 114,488 Cash 2025: € 114,488 ▲ € 95,326 vs 2024 (€ 19,162) Favourable step	▲ € 95,326
Land & buildings	€ 277,821 Land & buildings 2022: € 277,821 First fiscal year in the series	€ 466,552 Land & buildings 2023: € 466,552 ▲ 68% vs 2022 (€ 277,821) Unchanged	€ 450,028 Land & buildings 2024: € 450,028 ▼ 4% vs 2023 (€ 466,552) Unchanged	€ 223,270 Land & buildings 2025: € 223,270 ▼ 50% vs 2024 (€ 450,028) Unchanged	▼ 50%
Retained profit	€ -207,882 Retained profit 2022: € -207,882 First fiscal year in the series	€ -215,245 Retained profit 2023: € -215,245 ▼ € 7,364 vs 2022 (€ -207,882) Unfavourable step	€ -211,740 Retained profit 2024: € -211,740 ▲ € 3,506 vs 2023 (€ -215,245) Favourable step	€ 58,088 Retained profit 2025: € 58,088 ▲ € 269,828 vs 2024 (€ -211,740) Favourable step	▲ € 269,828
Bank debt	€ 181,318 Bank debt 2022: € 181,318 First fiscal year in the series	€ 157,976 Bank debt 2023: € 157,976 ▼ 13% vs 2022 (€ 181,318) Favourable step	€ 154,867 Bank debt 2024: € 154,867 ▼ 2% vs 2023 (€ 157,976) Favourable step	€ 94,699 Bank debt 2025: € 94,699 ▼ 39% vs 2024 (€ 154,867) Favourable step	▼ 39%
Balance sheet total	€ 332,562 Balance sheet total 2022: € 332,562 First fiscal year in the series	€ 504,077 Balance sheet total 2023: € 504,077 ▲ 52% vs 2022 (€ 332,562) Unchanged	€ 482,257 Balance sheet total 2024: € 482,257 ▼ 4% vs 2023 (€ 504,077) Unchanged	€ 340,910 Balance sheet total 2025: € 340,910 ▼ 29% vs 2024 (€ 482,257) Unchanged	▼ 29%

Key figures of ALGEMENE AANNEMING ANTWERPEN THERMAC, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to ALGEMENE AANNEMING ANTWERPEN THERMAC?

What happened at ALGEMENE AANNEMING ANTWERPEN THERMAC in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jul 3, 2026 New annual accounts for financial year 2025: profit of € 269,828 (▲ € 266,322 vs 2024). Source: NBB ↗
Aug 12, 1985 New establishment in Antwerpen. KBO
Aug 12, 1985 Start of the company according to the CBE. KBO

In short

From € 38,964 profit in 2022 to € 269,828 profit in 2025.

Paid € 13,973 in corporate taxes since 2022.

Best year ever: 2025, with € 269,828 profit.

Original PDFs at the National Bank ↗

Management

Holding LVT 100%

The stake of Holding LVT comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.

ALGEMENE AANNEMING ANTWERPEN THERMAC

Behind ALGEMENE AANNEMING ANTWERPEN THERMAC is Holding LVT BV. The shares are held by Holding LVT (100%).

Directors

According to the 2025 annual accounts

Holding LVT BV

Director · represented by Luc Van Thillo Luc

Also active at: REBUS, Art Salvage Belgium, INFRALIER, ROBOTLAND, Jabbedabbedoe, Boost-it-up, CX Essen, Comedy Communication Media.be +1 more

Shareholders

Holding LVT

100%

Participations

No participations in other companies reported.

Establishments

Establishment units

Physical locations of this company

Registered office

Hemelrijk 36

2910 Essen

2.027.608.321

Ter Rivierenlaan 233

2100 Antwerpen

Active since 12 August 1985

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 3 companies are registered at this address.

All companies at this address →

Robotland met Suske en Wiske & molen

ROBOTLAND same network

€ 417,279 gross margin · 2025

Jabbedabbedoe same network

€ 2,681 gross margin · 2025

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0427.579.463
VAT number: BE 0427.579.463
Registered office: Hemelrijk 36, 2910 Essen
Names & denominations: ALGEMENE AANNEMING ANTWERPEN THERMAC
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 12 August 1985
Peppol: Active · Active since 10 Jan 2025

View on CBE Public ↗ Annual accounts (NBB) ↗